HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anti-arrhythmic effects of a new calcium antagonist, monatepil, AJ-2615, in experimental arrhythmic models [corrected].

Abstract
1. To characterize the anti-arrhythmic properties of a new calcium antagonist, monatepil [corrected], AJ-2615, the preventive effects of AJ-2615 were compared with those of the existing calcium antagonists, diltiazem and verapamil, in experimental models of arrhythmia. 2. AJ-2615 (0.1-3.0 mg/kg, i.v.) suppressed ventricular arrhythmias induced by adrenaline (10 micrograms/kg, i.v.) in rats. AJ-2615 (0.1 mg/kg per min for 2 min, i.v.) also suppressed atrial tachycardia induced by aconitine (0.01% aconitine solution) in rats. 3. In these activities, AJ-2615 was comparable to or more potent than diltiazem and verapamil which are widely used for the treatment of arrhythmia. 4. In pro-arrhythmic activity, AJ-2615 was less potent than diltiazem and verapamil. 5. These results suggest that AJ-2615 would be a safer anti-arrhythmic agent, with less proarrhythmic liability than diltiazem and verapamil.
AuthorsT Yamamoto, K Hosoki, T Karasawa
JournalClinical and experimental pharmacology & physiology (Clin Exp Pharmacol Physiol) 1993 Jul-Aug Vol. 20 Issue 7-8 Pg. 497-500 ISSN: 0305-1870 [Print] Australia
PMID8403530 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Calcium Channel Blockers
  • Dibenzothiepins
  • Piperazines
  • Verapamil
  • Diltiazem
  • monatepil
  • Aconitine
  • Epinephrine
Topics
  • Aconitine (toxicity)
  • Animals
  • Arrhythmias, Cardiac (chemically induced, drug therapy)
  • Calcium Channel Blockers (administration & dosage, therapeutic use, toxicity)
  • Dibenzothiepins (administration & dosage, therapeutic use, toxicity)
  • Diltiazem (administration & dosage, therapeutic use, toxicity)
  • Disease Models, Animal
  • Epinephrine (toxicity)
  • Injections, Intravenous
  • Male
  • Piperazines (administration & dosage, therapeutic use, toxicity)
  • Rats
  • Rats, Wistar
  • Tachycardia (drug therapy, prevention & control)
  • Verapamil (administration & dosage, therapeutic use, toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: